Application

16837910 · Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

Filed 2020-04-01 · Granted · Patent 11590204 (2023-02-28) The official file ↗The patent and its PDF ↗ · Art unit 1654 · Examiner Kristina M Hellman Typical · CPC A61K 9/19 · BioMarin Pharmaceutical Inc. · Marshall, Gerstein & Borun LLP (Biomarin)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

16.6 mo

to disposition 34.9 mo

Statutes raised

103 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.